Altogen Labs extensive biotechnology and pharmacology research services include the following:

Pharmacology and toxicology testing: IC50 for Tumor Cell Lines

Request a quote

Over 50 assays for median inhibition concentration determination (IC50).

Cell lines available for IC50 compound in vitro testing:

 A549 :: (human lung carcinoma cells)
 Astrocytes :: (primary astrocyte cells)
 HCN-1A :: (human cortical neuronal cells)
 CLBPEC :: (human neuroblastoma cells)
 HeLa :: (human cervix adenocarcinoma cells)
 HepG2 :: (human hepatocellular carcinoma cells)
 Cos-7 :: (monkey kidney cells)
 ASMC :: (aortic smooth muscle cells)
 DU145 :: (human prostate cancer cells)
 AsPC-1 :: (human pancreatic cells)
 FaDu :: (human hypopharyngeal carcinoma cells)
 Fibroblasts :: (primary fibroblast cells)
 HMEC :: (human mammary epithelial cancer cells)
 HUVEC :: (umbilical vein endothelial cells)
 MDA-MB :: (breast cancer cells)
 HCAEC :: (human coronary artery endothelial cells)
 HuH-7 :: (human hepatoma cells)
 BMS2 :: (bone marrow stromal cells)
 Caki-1 :: (renal carcinoma cells)
 Calu-6 :: (human renin-expressing cells)
 CFPEo :: (human trachea epithelium cells)
 CHO :: (hamster ovary epithelial cells)
 Chromaffin cells :: (chromaffin cell cultures)
 D-407 :: (retinal pigment epithelial cells)
 D-451 :: (murine fibroblast cells)
 DI-TNC1 :: (rat brain astrocyte cells)
 HEK-293 :: (human epithelial kidney cells)
 HSC-2 :: (human chondrocyte-like cells)
 HT-29 :: (human colorectal adenocarcinoma cells)
 HTB :: (human osteosarcoma cells)
 KB :: (human mouth epidermal carcinoma cells)
 Keratinocyte :: (keratinocyte cells)
 L929 :: (murine fibrosarcoma cells)
 LNCaP :: (prostate cancer cells)
 MA-10 :: (Leydig tumour cells)
 MCF-7 :: (human breast cancer cells)
 MEF :: (murine embryonic fibroblast cells)
 MES :: (mouse embryonic stem cells)
 MM39 :: (human tracheal gland cells)
 MRC-5 :: (human diploid fibroblast cells)
 NIH3T3 :: (mouse fibroblast cells)
 NRK :: (normal rat kidney epithelial cells)
 P815 :: (murine mastocytoma cells)
 PAE :: (porcine aortic endothelial cells)
 PANC :: (human pancreatic cancer cells)
 PC-12 :: (rat pheochromocytoma cells)
 PC-3 :: (human prostate cancer cells)
 PGHAM :: (hamster pancreatic carcinoma cells)
 PHC :: (primary hepatocarcinoma cells)
 PS-1 :: (prostate smooth muscle cells)
 RAW-1 :: (murine macrophage cells)
 WERI-Rb-1 :: (retinoblastoma cells)
 SaOS :: (human osteoblastic cells)
 SHEP :: (human neuroblastoma cells)
 SKNAS :: (bone marrow neuroblastoma cells)
 SK-N-MC :: (neuroblastoma cells)
 SW-13 :: (human adrenocortical carcinoma cells)
 U87 :: (glioblastoma cells)
 VERO :: (African green monkey kidney cells)
 3LL :: (murine Lewis lung carcinoma cells)

Standard Service Quote:
Service ID: IC50 In Vitro Compound Screening 
Service description: Cell-based assay in 96-well format.
Phenotype: Dose-response inhibition of cancer cell line proliferation
Test performed in following cell lines of interest: HepG2, HEPA and normal human fibroblast cells (3)
Number of compounds:
Negative control group: 1
Assay type: Dose-response
Number of each compound concentrations to test: 10
Cell-cased assay sample replicates: Duplicate
Total number of samples (data points): 240
Estimated timeline: 2 weeks
Price: $4,250

GLP Compliant


see also: Pharmacology and toxicology testing: IC50 for Tumor Cell Lines | Xenograft Animal Service: Immunocompromised NOD/SCID Mice | Therapeutic RNAi development: targeted siRNA, qPCR assays | Liposome Encapsulation services: siRNA, miRNA, DNA, proteins | ELISA and Cell-Based Assay Development (Cell Cycle, Viability) | Apoptosis Assay: Caspase-3 and Caspase-7 Cell Line Screen | RNAi Consulting Services: technology delevopment & evaluation